EU discusses plan to counter bioterrorism
The Commission and representatives of the pharmaceutical industry have discussed plans this week for an EU-wide strategy to ensure production, supply and availability of medicinal products for preventing or treating the effects of a biological attack. The Commission and industry representatives explored mechanisms that could be set up to counter possible attacks by biological agents such as Anthrax or Smallpox.
The Commission and representatives of the pharmaceutical industry have discussed plans this week for an EU-wide strategy to ensure production, supply and availability of medicinal products for preventing or treating the effects of a biological attack. The Commission and industry representatives explored mechanisms that could be set up to counter possible attacks by biological agents such as Anthrax or Smallpox.
